Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Tisagenlecleucel Submitted for European Approval for ALL, DLBCL

Jason Harris
Published: Monday, Nov 06, 2017

Gilles A. Salles, MD, PhD

Gilles A. Salles, MD, PhD
The European Medicines Agency (EMA) has received a Marketing Authorization Application (MAA) for tisagenlecleucel (Kymriah) for 2 forms of advanced lymphoma.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication